![Andrew Robbins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Robbins
Directeur Général chez
COGENT BIOSCIENCES, INC.
Fortune : 23 M $ au 31/08/2026
Profil
Andrew R.
Robbins is President, Chief Executive Officer & Director at Cogent Biosciences, Inc. since 2020.
Mr. Robbins is Independent Director at Turmeric Acquisition Corp.
since 2020.
Former roles include Independent Director at Harpoon Therapeutics, Inc. from 2020 to 2024; Chief Operating Officer at Array BioPharma, Inc. from 2015 to 2019; Senior Vice President-Commercial Operations at Pfizer Inc. from 2012 to 2015; General Manager & Vice President at Hospira, Inc. from 2007 to 2012; and Director positions at Cytograft Tissue Engineering, Inc., StemCor Systems, Inc., and Fate Therapeutics, Inc. Education includes undergraduate studies at Swarthmore College and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC. 0,38 % | 19/05/2026 | 657 503 ( 0,38 % ) | 23 M $ | 31/08/2026 |
Postes actifs de Andrew Robbins
| Sociétés | Poste | Début |
|---|---|---|
| TURMERIC ACQUISITION CORP. | Directeur/Membre du Conseil | 01/10/2020 |
| COGENT BIOSCIENCES, INC. | Directeur Général | 23/10/2020 |
Anciens postes connus de Andrew Robbins
| Sociétés | Poste | Fin |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/03/2024 |
| ARRAY TECHNOLOGIES, INC. | Directeur des opérations | 01/01/2019 |
| PFIZER INC. | Directeur des opérations | 01/03/2015 |
| HOSPIRA, INC. | Corporate Officer/Principal | 01/07/2012 |
StemCor Systems, Inc.
 StemCor Systems, Inc. Medical SpecialtiesHealth Technology Develops proprietary and minimally-invasive bone marrow collection systems | Directeur/Membre du Conseil | - |
Formation de Andrew Robbins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Cytograft Tissue Engineering, Inc.
 Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Develops cardiovascular medicine | Health Technology |
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology Develops proprietary and minimally-invasive bone marrow collection systems | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Swarthmore College
 Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
